Developer docs
API playgroundTry for free, no card

Search company profiles

DolCas Biotech

Full company profile

uuid000ovss

Namestring
DolCas Biotech
Legal namestring
DolCas Biotech, LLC.
Company typeenum
Private
Founded yearint
2007
Descriptiontext

DolCas Biotech is a private B2B branded nutraceutical ingredients company headquartered in Landing, New Jersey, founded in 2007. The firm develops, manufactures, and commercializes proprietary botanical and marine-derived ingredient formulations sold to dietary supplement manufacturers and functional food/beverage producers. Its portfolio comprises eight branded ingredient SKUs — TruOliv, Morikol, MMP50, Curcugen, Fortiquin, Bergacyn FF, NitrateBurst, and Ginfort — each supported by clinical studies, patent applications or proprietary process IP, and regulatory credentials including GRAS, USDA Organic, EU Organic, and Zero-Carbon certification for TruOliv. The core technical differentiation rests on proprietary processing technologies, including water-dispersible curcumin (Curcugen), hydroxytyrosol-rich olive fruit extract (TruOliv), and enzyme-hydrolyzed chicken cartilage type II collagen (Fortiquin), with clinical positioning around bioavailability enhancement and structure-function claims.

Manufacturing is anchored by DolCas Botanosys, a vertically integrated production arm established in 2017 in Bikaner, India, which provides proprietary raw material control and white-label contract manufacturing capability. The firm operates a sales-led B2B go-to-market with three revenue streams: branded ingredient sales, contract manufacturing services, and licensing/co-marketing arrangements. Major channel partnerships include a 2020 distribution agreement with IFF Health for Curcugen and a 2025 partnership with Cosmos Health for North American domestic manufacturing. New product formats such as the 2026 Morikol single-serving sachet target the functional food/beverage channel beyond traditional supplement capsules. Trade show presence at Vitafoods Europe and SupplySide Global supports customer acquisition. The company is privately held with no disclosed funding rounds, no public revenue, and an 11–50 employee footprint.

Short descriptiontext

DolCas Biotech is a private B2B branded nutraceutical ingredients company that develops and commercializes eight clinically-backed botanical and marine-derived extracts for dietary supplement and functional food/beverage manufacturers, supported by vertically integrated manufacturing in India.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMays Landing, United States
HQ citystring
Mays Landing
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
branded nutraceutical ingredients, botanical extract manufacturing, marine collagen tripeptides, bioavailable curcumin extract, dietary supplement ingredients
Industry4 codes
PRIMARYAFADAKAF
Phytogenics & Botanicals (Essential Oils, Plant Extracts)
Agriculture & Food Production/Animal Feed Manufacturing/Medicated & Functional Feed (Coccidiostats, Probiotics, Performance Additives)
SECONDARYCRADAOAO
Ingredient Blends & Systems / Custom Formulation (Seasoning Systems, Functional Blends)
SECONDARYCRADAOAM
Fortification Ingredients (Vitamins, Minerals, Nutrient Premixes)
SECONDARYCRADAGAD
Herbal & Botanical Supplements
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Food And Kindred Products2000
Product category
Nutraceutical Ingredients
No data
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Branded Ingredient Sales
TypeOne Time License
Description

Sale of proprietary branded nutraceutical ingredients including TruOliv, Morikol, MMP50, Curcugen, Fortiquin, Bergacyn FF, and NitrateBurst to dietary supplement, functional food, and beverage manufacturers. Revenue derived from ingredient product sales with varying order quantities.

dolcas-biotech.com
2Contract Manufacturing Services
TypeProfessional Services
Description

Custom manufacturing and finishing services including liquid-filled 2-piece hard shell capsules, leveraging vertically integrated supply chain with DolCas Botanosys manufacturing facility in India. Supports customers from ideation through creation with reduced manufacturing minimums.

pharmiweb.com
3Licensing and Co-Marketing Agreements
TypeLicensing Royalties
Description

Strategic licensing and marketing partnerships such as the IFF Health partnership for Curcugen distribution. Exclusive distribution agreements and co-marketing arrangements with major ingredient distributors.

dolcas-biotech.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1TruOliv®
Description

USDA and EU-certified whole olive tree extract with hydroxytyrosol and oleuropein from fruit and leaf, enriched by Saharan Desert conditions.

dolcas-biotech.com
+7 more records
Core offering1 text field

DolCas Biotech develops, manufactures, and markets proprietary branded nutraceutical ingredients — botanical and marine-derived extracts — for use by dietary supplement, functional food, and beverage manufacturers. The portfolio includes eight standardized branded ingredients (TruOliv, Morikol, MMP50, Curcugen, Fortiquin, Bergacyn FF, NitrateBurst, Ginfort) supported by clinical research, regulatory dossiers, and a vertically integrated manufacturing arm (DolCas Botanosys) in India. The company also offers custom contract manufacturing and finishing services to customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 39X enhanced bioavailability of free curcumin vs. C-95, demonstrated in 18-subject pharmacokinetic study
+4 more records
Product overview1 text field

DolCas Biotech offers a portfolio of branded nutraceutical ingredients focused on botanical and marine-derived extracts. The company operates with a vertically integrated structure including its own manufacturing arm DolCas Botanosys in India. The portfolio includes eight distinct branded ingredients: TruOliv® (olive polyphenols), Morikol® (marine collagen tripeptides), MMP50® (green-lipped mussel extract), Curcugen® (turmeric/curcumin), Fortiquin® (male sexual stamina blend), Bergacyn®FF (liver/metabolic health), NitrateBurst® (plant nitrates for cardiovascular support), and Ginfort® (ginger extract). These ingredients are marketed with science-backed positioning, clinical research support, and exclusivity in the marketplace, targeting dietary supplement, functional food, and beverage manufacturers.

Product and service8 records
1TruOliv
CategoryBranded ingredient
Description

USDA and EU-certified whole olive tree extract with hydroxytyrosol and oleuropein from fruit and leaf, sourced from Moroccan Saharan Desert conditions that enrich polyphenol content. Solvent-free, organic polyphenol extract standardized to 10% total polyphenols, 6% oleuropein, and 2% hydroxytyrosol, intended for dietary supplement and functional food manufacturers.

2Morikol
CategoryBranded ingredient
Description

Marine collagen tripeptide formula derived from fish, featuring very low molecular weight tripeptides (average 300 Da) standardized to minimum 15% tripeptide concentration, clinically proven to support skin and joint health at 1g/day dose. Tripeptides absorb intact through PEPT1 receptors; intended for supplement and functional food manufacturers.

3MMP50
CategoryBranded ingredient
Description

New Zealand green-lipped whole-mussel extract retaining biological activity through proprietary shell extraction that avoids cooking, heating, or steaming. Standardized for bioactivity using MMP-inhibition assay, supporting joint health through MMP enzyme inhibition (MMPs 1-14); targeted at supplement manufacturers.

4Curcugen
CategoryBranded ingredient
Description

Dispersible, clinically-studied whole turmeric extract delivering 39X enhanced curcuminoid bioavailability compared to standard curcumin 95%. Oleoresin-based formula retaining turmeric-native actives including polar resins, essential oils, and curcuminoid analogues at natural ratios; GRAS self-affirmed and standardized to 50% curcuminoids for dietary supplement and food/beverage manufacturers.

5Fortiquin
CategoryBranded ingredient
Description

Patent-pending standardized 5-ingredient blend of botanical extracts (mucuna, fenugreek, ashwagandha, artichoke) and L-arginine, clinically shown to support male sexual stamina. Standardized to minimum 20% saponins and 1.5% total flavonoids; clinical study reported 5.1X improvement in endurance over placebo at 450mg twice daily.

6Bergacyn FF
CategoryBranded ingredient
Description

Patented extract blend of bergamot citrus and Cynara cardunculus clinically proven to support normal liver fat levels and healthy weight loss. Solvent-free, free-flowing formulation with 17% polyphenols and 5% cynaropicrin, effective at 600mg/day; published study reported 9.6 lbs weight loss versus 5.2 lbs placebo over 12 weeks.

7NitrateBurst
CategoryBranded ingredient
Description

Green spinach extract delivering 9% phytonitrates and 13% plant-based potassium, supporting healthy blood pressure, cardiovascular health, and athletic endurance through an oxygen-independent nitric oxide pathway. Water-soluble, solvent-free extract used in 1-2g/day dose range.

8Ginfort
CategoryBranded ingredient
Description

Patented, highly stable concentrated gingeroids extract standardized to 26% actives, solvent-free, with clinically-proven benefits in relieving symptoms of functional dyspepsia.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierFlagshipTypeChannel Partner/ Reseller/ DistributorAnnounced on2020-08-26
Description

IFF Health, part of International Flavors & Fragrances, partnered with DolCas Biotech on the sale and marketing of Curcugen, a next-generation, all-natural turmeric extract for both dietary supplement and food and beverage industries. IFF Health handles the commercial distribution and marketing of this branded ingredient leveraging its global ingredient distribution network.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Sabinsa is a leading manufacturer and global supplier of patented, science-backed branded nutraceutical ingredients (e.g., Curcumin C3 Complex, BioPerine, ForsLean) with vertically integrated manufacturing and clinical research programs, directly comparable to DolCas's branded botanical ingredient model.

TypeDirect peer
Description

OmniActive develops proprietary, clinically studied branded nutraceutical ingredients such as Lutemax, CurcuWIN, and Capsimax, targeting dietary supplement and F&B manufacturers. It mirrors DolCas's branded botanical positioning, clinical evidence strategy, and global B2B sales approach.

TypeDirect peer
Description

PLT Health Solutions is a branded ingredient supplier focused on plant-based and marine-sourced extracts backed by clinical research, selling into supplement and functional food manufacturers. Its portfolio, science-led sales motion, and exclusive-distribution approach directly parallel DolCas.

4Gencor
TypeDirect peer
Description

Gencor is a branded ingredient company offering clinically validated botanical and marine extracts (e.g., Levagen+, Gencor PEA, AquaLOX) with patent positions and global distribution, directly comparable to DolCas's branded botanical/nutraceutical ingredient strategy.

TypeDirect peer
Description

Nutriventia (an Inventia Healthcare company) supplies patented branded nutraceutical ingredients with proprietary delivery technologies targeting bioavailability and clinical efficacy, comparable to DolCas's Curcugen Self-D and Morikol tripeptide technologies.

TypeBroad incumbent
Description

Kerry Group's Health and Life Sciences arm supplies branded bioactive ingredients, probiotics, and functional food components to global supplement and F&B manufacturers. As a multi-billion-dollar public ingredient platform, it is a broader incumbent serving overlapping customers.

TypeBroad incumbent
Description

ADM's Health & Wellness division offers a broad portfolio of branded nutritional ingredients, botanicals, and functional food solutions to manufacturers globally, competing with DolCas in supplement and F&B manufacturer accounts as a large-scale incumbent.

TypeBroad incumbent
Description

IFF Health is a global ingredient powerhouse that not only distributes DolCas's Curcugen but also develops and markets its own branded nutritional and botanical ingredients, positioning it as both a strategic partner and broad incumbent competitor in the same space.

9Lallemand Health Solutions
TypeDirect peer
Description

Lallemand Health Solutions offers branded, clinically documented probiotic and natural ingredient solutions for human health and nutrition, targeting dietary supplement and functional food manufacturers with proprietary strains and science-led positioning.

TypeEmerging player
Description

Ingredients by Nature supplies branded, science-backed botanical extracts (e.g., Pomella, LearnGo) for dietary supplement and functional food applications, with a comparable branded-ingredient model to DolCas but smaller portfolio and reach.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

DolCas Biotech

Nutraceutical Ingredientsdolcas-biotech.com

DolCas Biotech is a private B2B branded nutraceutical ingredients company that develops and commercializes eight clinically-backed botanical and marine-derived extracts for dietary supplement and functional food/beverage manufacturers, supported by vertically integrated manufacturing in India.

What DolCas Biotech does

DolCas Biotech is a private B2B branded nutraceutical ingredients company headquartered in Landing, New Jersey, founded in 2007. The firm develops, manufactures, and commercializes proprietary botanical and marine-derived ingredient formulations sold to dietary supplement manufacturers and functional food/beverage producers. Its portfolio comprises eight branded ingredient SKUs — TruOliv, Morikol, MMP50, Curcugen, Fortiquin, Bergacyn FF, NitrateBurst, and Ginfort — each supported by clinical studies, patent applications or proprietary process IP, and regulatory credentials including GRAS, USDA Organic, EU Organic, and Zero-Carbon certification for TruOliv. The core technical differentiation rests on proprietary processing technologies, including water-dispersible curcumin (Curcugen), hydroxytyrosol-rich olive fruit extract (TruOliv), and enzyme-hydrolyzed chicken cartilage type II collagen (Fortiquin), with clinical positioning around bioavailability enhancement and structure-function claims.

Manufacturing is anchored by DolCas Botanosys, a vertically integrated production arm established in 2017 in Bikaner, India, which provides proprietary raw material control and white-label contract manufacturing capability. The firm operates a sales-led B2B go-to-market with three revenue streams: branded ingredient sales, contract manufacturing services, and licensing/co-marketing arrangements. Major channel partnerships include a 2020 distribution agreement with IFF Health for Curcugen and a 2025 partnership with Cosmos Health for North American domestic manufacturing. New product formats such as the 2026 Morikol single-serving sachet target the functional food/beverage channel beyond traditional supplement capsules. Trade show presence at Vitafoods Europe and SupplySide Global supports customer acquisition. The company is privately held with no disclosed funding rounds, no public revenue, and an 11–50 employee footprint.

DolCas Biotech firmographics

Firmographics
Name
DolCas Biotech
Legal name
DolCas Biotech, LLC.
Website
https://dolcas-biotech.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
11–50 employees
Short description
DolCas Biotech is a private B2B branded nutraceutical ingredients company that develops and commercializes eight clinically-backed botanical and marine-derived extracts for dietary supplement and functional food/beverage manufacturers, supported by vertically integrated manufacturing in India.
Ownership category
akta.pro rank

DolCas Biotech industry classification

Industry
Product category
Nutraceutical Ingredients
NAICS
Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833), Food And Kindred Products (2000)
akta.pro industry
PRIMARYAFADAKAF
Phytogenics & Botanicals (Essential Oils, Plant Extracts)
Agriculture & Food Production/Animal Feed Manufacturing/Medicated & Functional Feed (Coccidiostats, Probiotics, Performance Additives)
SECONDARYCRADAOAO
Ingredient Blends & Systems / Custom Formulation (Seasoning Systems, Functional Blends)
SECONDARYCRADAOAM
Fortification Ingredients (Vitamins, Minerals, Nutrient Premixes)
SECONDARYCRADAGAD
Herbal & Botanical Supplements

Keywords

  • Branded nutraceutical ingredients
  • Botanical extract manufacturing
  • Marine collagen tripeptides
  • Bioavailable curcumin extract
  • Dietary supplement ingredients

Where DolCas Biotech is headquartered

Location

Headquarters

HQ city
Mays Landing
HQ country
United States
HQ region
North America

Offices2 records

Markets served

DolCas Biotech business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

  1. Branded Ingredient Sales: Sale of proprietary branded nutraceutical ingredients including TruOliv, Morikol, MMP50, Curcugen, Fortiquin, Bergacyn FF, and NitrateBurst to dietary supplement, functional food, and beverage manufacturers. Revenue derived from ingredient product sales with varying order quantities.
  2. Contract Manufacturing Services: Custom manufacturing and finishing services including liquid-filled 2-piece hard shell capsules, leveraging vertically integrated supply chain with DolCas Botanosys manufacturing facility in India. Supports customers from ideation through creation with reduced manufacturing minimums.
  3. Licensing and Co-Marketing Agreements: Strategic licensing and marketing partnerships such as the IFF Health partnership for Curcugen distribution. Exclusive distribution agreements and co-marketing arrangements with major ingredient distributors.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

DolCas Biotech product offering

Product offering

Core offering

DolCas Biotech develops, manufactures, and markets proprietary branded nutraceutical ingredients — botanical and marine-derived extracts — for use by dietary supplement, functional food, and beverage manufacturers. The portfolio includes eight standardized branded ingredients (TruOliv, Morikol, MMP50, Curcugen, Fortiquin, Bergacyn FF, NitrateBurst, Ginfort) supported by clinical research, regulatory dossiers, and a vertically integrated manufacturing arm (DolCas Botanosys) in India. The company also offers custom contract manufacturing and finishing services to customers.

Product overview

DolCas Biotech offers a portfolio of branded nutraceutical ingredients focused on botanical and marine-derived extracts. The company operates with a vertically integrated structure including its own manufacturing arm DolCas Botanosys in India. The portfolio includes eight distinct branded ingredients: TruOliv® (olive polyphenols), Morikol® (marine collagen tripeptides), MMP50® (green-lipped mussel extract), Curcugen® (turmeric/curcumin), Fortiquin® (male sexual stamina blend), Bergacyn®FF (liver/metabolic health), NitrateBurst® (plant nitrates for cardiovascular support), and Ginfort® (ginger extract). These ingredients are marketed with science-backed positioning, clinical research support, and exclusivity in the marketplace, targeting dietary supplement, functional food, and beverage manufacturers.

Differentiator

Problem solved

Functional benefit

Brands

  • TruOliv®: USDA and EU-certified whole olive tree extract with hydroxytyrosol and oleuropein from fruit and leaf, enriched by Saharan Desert conditions.
  • Morikol®
  • MMP50®
  • Curcugen®
  • Fortiquin®
  • Bergacyn®FF
  • NitrateBurst®
  • Ginfort®

Products and services

  • TruOliv USDA and EU-certified whole olive tree extract with hydroxytyrosol and oleuropein from fruit and leaf, sourced from Moroccan Saharan Desert conditions that enrich polyphenol content. Solvent-free, organic polyphenol extract standardized to 10% total polyphenols, 6% oleuropein, and 2% hydroxytyrosol, intended for dietary supplement and functional food manufacturers.
  • Morikol Marine collagen tripeptide formula derived from fish, featuring very low molecular weight tripeptides (average 300 Da) standardized to minimum 15% tripeptide concentration, clinically proven to support skin and joint health at 1g/day dose. Tripeptides absorb intact through PEPT1 receptors; intended for supplement and functional food manufacturers.
  • MMP50 New Zealand green-lipped whole-mussel extract retaining biological activity through proprietary shell extraction that avoids cooking, heating, or steaming. Standardized for bioactivity using MMP-inhibition assay, supporting joint health through MMP enzyme inhibition (MMPs 1-14); targeted at supplement manufacturers.
  • Curcugen Dispersible, clinically-studied whole turmeric extract delivering 39X enhanced curcuminoid bioavailability compared to standard curcumin 95%. Oleoresin-based formula retaining turmeric-native actives including polar resins, essential oils, and curcuminoid analogues at natural ratios; GRAS self-affirmed and standardized to 50% curcuminoids for dietary supplement and food/beverage manufacturers.
  • Fortiquin Patent-pending standardized 5-ingredient blend of botanical extracts (mucuna, fenugreek, ashwagandha, artichoke) and L-arginine, clinically shown to support male sexual stamina. Standardized to minimum 20% saponins and 1.5% total flavonoids; clinical study reported 5.1X improvement in endurance over placebo at 450mg twice daily.
  • Bergacyn FF Patented extract blend of bergamot citrus and Cynara cardunculus clinically proven to support normal liver fat levels and healthy weight loss. Solvent-free, free-flowing formulation with 17% polyphenols and 5% cynaropicrin, effective at 600mg/day; published study reported 9.6 lbs weight loss versus 5.2 lbs placebo over 12 weeks.
  • NitrateBurst Green spinach extract delivering 9% phytonitrates and 13% plant-based potassium, supporting healthy blood pressure, cardiovascular health, and athletic endurance through an oxygen-independent nitric oxide pathway. Water-soluble, solvent-free extract used in 1-2g/day dose range.
  • Ginfort Patented, highly stable concentrated gingeroids extract standardized to 26% actives, solvent-free, with clinically-proven benefits in relieving symptoms of functional dyspepsia.

Quantifiable outcome

  • 39X enhanced bioavailability of free curcumin vs. C-95, demonstrated in 18-subject pharmacokinetic study
  • +4 more outcomes

Companies that use DolCas Biotech

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles2 records

DolCas Biotech technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

DolCas Biotech partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • IFF Health (International Flavors & Fragrances)flagshipChannel Partner/ Reseller/ Distributor · 26 August 2020IFF Health, part of International Flavors & Fragrances, partnered with DolCas Biotech on the sale and marketing of Curcugen, a next-generation, all-natural turmeric extract for both dietary supplement and food and beverage industries. IFF Health handles the commercial distribution and marketing of this branded ingredient leveraging its global ingredient distribution network.

Scale indicators3 records

Recent moves8 records

Expansion highlights5 records

DolCas Biotech competitors and assessment

Company assessment

Direct peers

  • Sabinsa: Sabinsa is a leading manufacturer and global supplier of patented, science-backed branded nutraceutical ingredients (e.g., Curcumin C3 Complex, BioPerine, ForsLean) with vertically integrated manufacturing and clinical research programs, directly comparable to DolCas's branded botanical ingredient model.
  • OmniActive Health Technologies: OmniActive develops proprietary, clinically studied branded nutraceutical ingredients such as Lutemax, CurcuWIN, and Capsimax, targeting dietary supplement and F&B manufacturers. It mirrors DolCas's branded botanical positioning, clinical evidence strategy, and global B2B sales approach.
  • PLT Health Solutions: PLT Health Solutions is a branded ingredient supplier focused on plant-based and marine-sourced extracts backed by clinical research, selling into supplement and functional food manufacturers. Its portfolio, science-led sales motion, and exclusive-distribution approach directly parallel DolCas.
  • Gencor: Gencor is a branded ingredient company offering clinically validated botanical and marine extracts (e.g., Levagen+, Gencor PEA, AquaLOX) with patent positions and global distribution, directly comparable to DolCas's branded botanical/nutraceutical ingredient strategy.
  • Nutriventia: Nutriventia (an Inventia Healthcare company) supplies patented branded nutraceutical ingredients with proprietary delivery technologies targeting bioavailability and clinical efficacy, comparable to DolCas's Curcugen Self-D and Morikol tripeptide technologies.
  • Lallemand Health Solutions: Lallemand Health Solutions offers branded, clinically documented probiotic and natural ingredient solutions for human health and nutrition, targeting dietary supplement and functional food manufacturers with proprietary strains and science-led positioning.

Broad incumbents

  • Kerry Group: Kerry Group's Health and Life Sciences arm supplies branded bioactive ingredients, probiotics, and functional food components to global supplement and F&B manufacturers. As a multi-billion-dollar public ingredient platform, it is a broader incumbent serving overlapping customers.
  • ADM (Health & Wellness): ADM's Health & Wellness division offers a broad portfolio of branded nutritional ingredients, botanicals, and functional food solutions to manufacturers globally, competing with DolCas in supplement and F&B manufacturer accounts as a large-scale incumbent.
  • IFF Health (International Flavors & Fragrances): IFF Health is a global ingredient powerhouse that not only distributes DolCas's Curcugen but also develops and markets its own branded nutritional and botanical ingredients, positioning it as both a strategic partner and broad incumbent competitor in the same space.

Emerging players

  • Ingredients by Nature: Ingredients by Nature supplies branded, science-backed botanical extracts (e.g., Pomella, LearnGo) for dietary supplement and functional food applications, with a comparable branded-ingredient model to DolCas but smaller portfolio and reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

DolCas Biotech compliance and trust

Trust signal

Compliance2 records

DolCas Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

DolCas Biotech leadership team

Management profile

Number of profiles

Profiles1 record

DolCas Biotech subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

DolCas Biotech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

DolCas Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DolCas Biotech

What does DolCas Biotech do?

DolCas Biotech develops, manufactures, and markets proprietary branded nutraceutical ingredients — botanical and marine-derived extracts — for use by dietary supplement, functional food, and beverage manufacturers. The portfolio includes eight standardized branded ingredients (TruOliv, Morikol, MMP50, Curcugen, Fortiquin, Bergacyn FF, NitrateBurst, Ginfort) supported by clinical research, regulatory dossiers, and a vertically integrated manufacturing arm (DolCas Botanosys) in India. The company also offers custom contract manufacturing and finishing services to customers.

Is DolCas Biotech a public or private company?

DolCas Biotech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was DolCas Biotech founded?

DolCas Biotech was founded in 2007. It employs 11 to 50 people.

Where is DolCas Biotech based?

DolCas Biotech is headquartered in Mays Landing, United States, in the North America region.

How does DolCas Biotech make money?

Three revenue lines are on record. Branded Ingredient Sales are the primary driver. The others are contract Manufacturing Services and licensing and Co-Marketing Agreements.

Who are DolCas Biotech's main competitors?

Direct peers on record are Sabinsa, OmniActive Health Technologies, PLT Health Solutions, Gencor, Nutriventia and Lallemand Health Solutions. Broad incumbents are Kerry Group, ADM (Health & Wellness) and IFF Health (International Flavors & Fragrances). Ingredients by Nature is listed as an emerging player.

Does DolCas Biotech have an API?

No public API is recorded for DolCas Biotech.

What industry is DolCas Biotech in?

DolCas Biotech's product category is Nutraceutical Ingredients. Its primary akta.pro industry code is AFADAKAF, Phytogenics & Botanicals (Essential Oils, Plant Extracts), with a secondary code of CRADAOAO, Ingredient Blends & Systems / Custom Formulation (Seasoning Systems, Functional Blends). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireDolCas Biotech: Beauty-From-Within Collagen Tripeptide Gets New Delivery FormatDolCas Biotech announced a new single-serving sachet format (1g and 2g) for its Morikol marine collagen tripeptide ingredient, to be showcased at Vitafoods Europe 2026 in Barcelona. The neutral-flavor, water-soluble powder can be consumed directly without mixing, offering consumers a convenient delivery option for the bioactive glycine-proline-hydroxyproline (GPH) tripeptide. Published clinical studies demonstrated a 10-fold improvement in wrinkle reduction and notable improvements in skin hydration and smoothness within 6–12 weeks at the 1–2g/day dose.openPR.comFish Powder Manufacturing Plant DPR - 2026: Investment Cost, Market Growth and MachineryIMARC Group published a detailed project report analyzing the global fish powder manufacturing sector, which is valued at USD 9.69 billion in 2025 and projected to reach USD 17.08 billion by 2034, growing at a CAGR of 6.5%. The report outlines investment requirements, operational costs (raw materials comprising 70-80% of OpEx), and projected profit margins of 25-35% gross and 12-20% net for plants with 5,000-20,000 MT annual capacity. Recent industry developments include Olam Agri's planned $200 million aquafeed facility in Ghana and DolCas Biotech's expansion of its marine collagen powder into functional beverages.TrendHunter.comFunctional Beverage Collagen Ingredients : Morikol marine collagenDolCas Biotech announced a new formulation of its Morikol marine collagen powder for functional beverages, designed to be odorless and flavorless. The low-molecular-weight collagen provides skin benefits at one gram and joint support at two grams, with no added enhancers. The product targets the clean-label nutraceutical market.PR NewswireDolCas Biotech Marine Collagen Boosts the Morning Coffee BreakLeading nutraceutical developer DolCas Biotech is expanding its Morikol marine collagen ingredient into the functional beverage market, targeting hot beverages such as coffee, tea, and cocoa, with the product to be showcased at the SupplySide Global trade show in Las Vegas on October 29-30. Morikol is a warm-water fish-derived collagen hydrolysate offering clinically proven benefits at low daily doses of 1g for skin beauty and 2g for joint health, with a proprietary process that delivers absorbable tripeptides. The collagen is already being used by Cup of Joe's Zend Wellness brand in its MetaGlow Collagen functional coffee product, and DolCas is positioning the ingredient for broader beverage applications as the better-for-you beverage market continues to grow at 9% compound annual growth.YahooCosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas BiotechCosmos Health Inc. has entered the U.S. market by executing a strategic agreement with DolCas Biotech LLC to commence production at GMP-certified facilities in New Jersey. This partnership aims to mitigate tariff exposure and logistical risks while enhancing production control for Cosmos Health's nutraceutical portfolio.FoodbevDolCas Biotech introduces marine collagen Morikol for functional beveragesDolCas Biotech, a nutraceutical developer, is expanding its marine collagen product Morikol into functional beverages, targeting hot drinks such as coffee, cocoa and tea. The ultra-low molecular weight powder, made from warm-water fish and containing bio-active tripeptides, is flavourless and odourless, and has already been used in Zend Wellness's MetaGlow Collagen coffee. It will be featured at SupplySide Global in Las Vegas on October 29-30.PR NewswireDolCas Biotech demonstrates Curcugen® in chocolate at VitafoodsDolCas Biotech announced it will introduce a chocolate prototype featuring its Curcugen® curcumin ingredient at Vitafoods Europe in Geneva, May 14-16, 2024, having partnered with a boutique chocolate maker to overcome flavor and texture challenges. The company also revealed strengthened distribution arrangements with IFF for the European market and opened new satellite offices in Delhi, India and Shanghai, China to support global expansion. The India office will coordinate with Curcugen's manufacturing facilities in Bikaner for global distribution, while the product delivers a clinically-supported 500mg dose of curcuminoids in a 65% dark chocolate matrix.TmcnetDolCas Biotech demonstrates Curcugen® in chocolate at VitafoodsDolCas Biotech will demonstrate Curcugen chocolate at Vitafoods Europe in Geneva, May 14-16, 2024. The 2x2-inch chocolate square delivers a 500mg dose of the turmeric extract, which supports gut mobility and mood health. The company also plans to open offices in Delhi and Shanghai to expand globally.PR NewswireDolCas Biotech and Clear Within Team Up for Beauty-from-Within SupplementClear Within selected DolCas Biotech's Curcugen turmeric extract for its vegan nutricosmetic supplement. The extract boosted free curcumin bioavailability 39-fold, allowing more actives in the formula. Curcumin market growth is projected at 12.5% CAGR through 2028.PR NewswireDolCas Biotech Gains Health Canada CertificationsDolCas Biotech, LLC has obtained two Health Canada natural product licenses for its Curcugen® turmeric extract (NPN# 80121176) and Ginfort® ginger extract (NPN# 80121222), both produced by Olene Life Sciences and solely distributed by DolCas. Products with these licenses have been assessed by Health Canada and found to be safe, effective, and of high quality. DolCas is already in discussions with finished product makers and private label companies in Canada, where the nutraceuticals market is projected to grow at a CAGR of 5.62% through 2027.